Jupiter Neurosciences (JUNS) grants 472,222 stock options to director
Rhea-AI Filing Summary
JUPITER NEUROSCIENCES, INC. reported that director Andrew Jon Cutler received a grant of 472,222 stock options under the 2025 Equity Incentive Plan in connection with his appointment to the Board of Directors, in lieu of cash annual board retainer and committee fees.
The options give the right to purchase 472,222 shares of Common Stock at an exercise price of $0.0900 per share, expire on July 31, 2036, and vest with 25 % upfront and the remainder in three quarterly installments beginning February 1, 2026, subject to continued service as a director.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Cutler Andrew Jon
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 472,222 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 472,222 shares (Direct)
Footnotes (1)
- F1. Represents a grant of 472,222 stock options (each representing the right to purchase one share of Common Stock) under the Issuer's 2025 Equity Incentive Plan. The options were granted in connection with the Reporting Person's appointment to the Board of Directors and the options were granted in lieu of cash compensation otherwise payable as an annual board retainer and committee fees. The options vest with 25 % upfront and the remaining vest in 3 quarterly installments beginning February 1, 2026, subject to the Reporting Person's continued service as a director through each vesting date.
Key Figures
Options granted: 472,222 stock options
Exercise price: $0.0900 per share
Underlying shares: 472,222 shares of Common Stock
+3 more
6 metrics
Options granted
472,222 stock options
Grant to director Andrew Jon Cutler under 2025 Equity Incentive Plan
Exercise price
$0.0900 per share
Exercise price for options to purchase Common Stock
Underlying shares
472,222 shares of Common Stock
Each option represents the right to purchase one share
Expiration date
July 31, 2036
Expiration of the granted stock options
Upfront vesting portion
25 %
Portion of options vesting immediately at grant
Remaining vesting schedule
3 quarterly installments beginning February 1, 2026
Vesting of remaining options subject to continued service
Key Terms
Stock Option (right to buy), 2025 Equity Incentive Plan, vesting, annual board retainer
4 terms
Stock Option (right to buy) financial
"Represents a grant of 472,222 stock options (each representing the right to purchase one share"
2025 Equity Incentive Plan financial
"under the Issuer's 2025 Equity Incentive Plan. The options were granted in connection"
vesting financial
"The options vest with 25 % upfront and the remaining vest in 3 quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual board retainer financial
"granted in lieu of cash compensation otherwise payable as an annual board retainer and committee fees"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Jupiter Neurosciences (JUNS) report for Andrew Jon Cutler?
Jupiter Neurosciences reported that director Andrew Jon Cutler was granted 472,222 stock options under the 2025 Equity Incentive Plan. The grant is tied to his appointment to the Board and replaces cash board and committee compensation he would otherwise receive.
What are the key terms of the 472,222 stock options granted by JUNS?
The grant consists of 472,222 options, each for one share of Common Stock at an exercise price of $0.0900 per share. The options expire on July 31, 2036, providing a long-dated equity incentive for the director’s service.
How do the Jupiter Neurosciences (JUNS) options granted to Andrew Jon Cutler vest?
The options vest with 25 % upfront, with the balance vesting in three quarterly installments starting February 1, 2026. Vesting is conditioned on Andrew Jon Cutler’s continued service as a director through each vesting date.
Why did Jupiter Neurosciences (JUNS) grant options instead of cash to Andrew Jon Cutler?
The company states the 472,222 options were granted in lieu of cash compensation otherwise payable as an annual board retainer and committee fees. This structure effectively replaces cash payments with equity-based compensation for the director role.
How many Jupiter Neurosciences (JUNS) options does Andrew Jon Cutler hold after this grant?
Following this transaction, Andrew Jon Cutler holds 472,222 stock options directly, as reported. Each option represents the right to purchase one share of Common Stock under the 2025 Equity Incentive Plan at the stated exercise price.